Skip to content

Understanding Your Laboratory Test: What It Is, Why It Is Done, and What Your Results Mean

Published: August 9, 2026Updated: August 16, 2026

A genetic blood test that analyzes the ACVRL1 and ENG genes to help diagnose hereditary hemorrhagic telangiectasia (HHT), a condition affecting blood vessels.

Quick summary

{"This test looks for genetic mutations in the ACVRL1 and ENG genes associated with HHT","HHT causes abnormal blood vessel formation leading to nosebleeds, skin lesions, and potential organ complications","A simple blood sample is all that's needed for this genetic analysis","Results help confirm diagnosis and guide family screening decisions","Results typically take 2-4 weeks as specialized genetic testing is performed"}

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
53837-1
Short code
ACVRL1 ENG MUT
Synonyms
ACVRL1+ENG gene Mut Anl Bld/T
Category
chemistry
Sample
whole-blood
Container
EDTA tube (purple top) or ACD tube
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
≥ 0 years
Method
molgen
CPT
81403
SNOMED
22943007
Specimen volume
3-5 mL whole blood
Stability
Room temperature: 72 hours; Refrigerated (2-8°C): 7 days; Frozen (-20°C or below): acceptable for extended storage
Hemolysis max
0
Lipemia max
0
Icterus max
0
TAT
336–1008 hours
Order
routine

This is a laboratory test that measures specific substances in a sample of your blood, urine, or other body fluid. Your healthcare provider uses the results to check how well your body is working, screen for certain health conditions, or monitor a treatment plan that is already in place.

The ACVRL1 and ENG gene mutation analysis is a specialized genetic test that examines your DNA to look for specific changes (mutations) in two genes called ACVRL1 and ENG. These genes are known to cause Hereditary Hemorrhagic Telangiectasia (HHT), a genetic disorder that affects blood vessels throughout the body.

Your provider may order this test as part of a routine checkup, to help find the cause of symptoms you are having, to confirm or rule out a suspected condition, or to see how well a medicine or other treatment is working over time. Testing can also help detect problems early, before symptoms appear.

Your healthcare provider may recommend this test if you have symptoms suggesting HHT, such as frequent nosebleeds, tiny red or purple spots on your skin (telangiectasias), or a family history of the condition. The test can also help determine if family members should be screened for HHT, as this condition is inherited.

The test is usually done with a small sample of blood drawn from a vein in your arm using a thin needle. The site is cleaned first, and the draw takes only a few minutes. Some tests use a urine sample or a simple finger stick instead. Afterward, a small bandage is placed on the site and you can go about your day.

A healthcare professional will collect a small blood sample from a vein in your arm. This sample is then sent to a specialized laboratory where scientists extract your DNA and analyze the ACVRL1 and ENG genes for specific mutations. The process involves molecular genetics techniques to identify any disease-causing changes in these genes.

Your results are compared with a reference range, which is the range of values typically seen in healthy people. Values that fall inside this range are generally considered normal, while results that are higher or lower may point to a condition that needs a closer look. Your provider will explain what your specific numbers mean and whether any follow-up testing or treatment is needed.

If a mutation is found in either the ACVRL1 or ENG gene, it confirms a diagnosis of HHT. If no mutation is found but you have symptoms, your doctor may consider other causes or recommend additional testing. A negative result in someone with a family history of HHT may indicate the person did not inherit the family mutation.

Reference range

Negative / No pathogenic mutation detected in ACVRL1 and ENG genesN/A

Specimen: whole-blood

No special preparation required. Informed consent for genetic testing may be required. Clinical history of hereditary hemorrhagic telangiectasia (HHT) symptoms should be provided including epistaxis, telangiectasias, AVM history, and family history.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

This test is crucial for confirming the diagnosis of Hereditary Hemorrhagic Telangiectasia (HHT), also known as Osler-Weber-Rendu syndrome. HHT affects approximately 1 in 5,000-10,000 people and causes abnormal blood vessel formation. These abnormal vessels can lead to serious complications including internal bleeding, iron deficiency anemia, brain arteriovenous malformations (AVMs), lung AVMs, and liver AVMs. Early diagnosis through genetic testing allows for proper monitoring and treatment to prevent serious complications.

The test also has significant implications for family members. Since HHT is an autosomal dominant disorder (meaning children have a 50% chance of inheriting it if a parent has the condition), identifying the specific genetic mutation in one family member allows for targeted testing of other family members. This enables early intervention and regular screening for at-risk relatives.

Frequently asked questions

Is fasting required before this test?
No, fasting is not required. You can eat and drink normally before the blood draw. However, always follow any specific instructions provided by your healthcare provider.
How long does it take to get results?
Results typically take 2-4 weeks because this is specialized genetic testing that requires detailed molecular analysis. Your healthcare provider will contact you when results are available.
Will my insurance cover this genetic test?
Coverage varies by insurance plan. Many insurance companies cover genetic testing when there is a medical indication such as symptoms or family history of HHT. It is recommended to check with your insurance provider about coverage and any required pre-authorization.
Does a negative result mean I don't have HHT?
Not necessarily. While this test looks for the most common genetic causes of HHT (mutations in ACVRL1 and ENG genes), there are rare cases where HHT may be caused by other genes or may not be identified by current testing methods. Your doctor will interpret the results in the context of your symptoms and family history.
Should my family members be tested?
If a mutation is found in you, your first-degree relatives (parents, siblings, and children) should discuss genetic testing with their healthcare providers. Early identification of affected family members allows for proper monitoring and treatment to prevent complications.
What happens if I test positive for a mutation?
If you test positive, your healthcare provider will likely recommend additional tests to check for complications of HHT, such as imaging of your lungs, brain, and liver. You will also need regular follow-up appointments to monitor for any developing abnormalities. Treatment options are available to manage symptoms and complications.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy